Announced Tue, 25 Aug, 2026 · 17:02 IST
ESG rating upgraded to 66 by CRISIL, now in 'strong' category
ZYDUSLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+5.6%1-day move
₹1124.50
prior close
₹1127.40
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.0+0.2-0.0-0.2+5.6+5.4+3.3+3.3+2.6-0.4+1.0+8.0——
Up moveDown movePending
AI summary
CRISIL has raised Zydus Lifesciences' overall ESG score to 66 from 61 for FY25-26, a 5-point improvement. The company now falls in the 'strong' rating band of 61-70 on CRISIL's framework. This reflects better environmental, social and governance practices at the company.
Likely market impact
Positive ESG profile may attract ESG-focused investors and strengthen brand and governance reputation.